Ardent Health Partners (NYSE:ARDT) Sets New 52-Week Low – Here’s What Happened

Ardent Health Partners, LLC (NYSE:ARDTGet Free Report)’s share price reached a new 52-week low during trading on Thursday . The stock traded as low as $12.34 and last traded at $12.84, with a volume of 617968 shares. The stock had previously closed at $12.97.

Analyst Ratings Changes

A number of research firms recently weighed in on ARDT. Truist Financial lowered their price objective on shares of Ardent Health Partners from $22.00 to $21.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. Royal Bank of Canada dropped their price target on shares of Ardent Health Partners from $23.00 to $21.00 and set an “outperform” rating on the stock in a research note on Tuesday, March 4th. Stephens restated an “overweight” rating and issued a $22.00 price objective on shares of Ardent Health Partners in a research report on Tuesday. JPMorgan Chase & Co. reiterated a “neutral” rating and set a $20.00 target price on shares of Ardent Health Partners in a research report on Tuesday, December 17th. Finally, Morgan Stanley reduced their price target on Ardent Health Partners from $23.50 to $22.00 and set an “overweight” rating for the company in a report on Tuesday, January 21st. Two analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Buy” and a consensus target price of $21.18.

Read Our Latest Analysis on Ardent Health Partners

Ardent Health Partners Trading Down 1.0 %

The company has a fifty day simple moving average of $14.34 and a two-hundred day simple moving average of $16.13. The company has a debt-to-equity ratio of 0.78, a current ratio of 1.91 and a quick ratio of 1.78.

Ardent Health Partners (NYSE:ARDTGet Free Report) last released its quarterly earnings data on Wednesday, February 26th. The company reported $0.81 EPS for the quarter, topping the consensus estimate of $0.50 by $0.31. The business had revenue of $1.61 billion during the quarter, compared to analysts’ expectations of $1.48 billion. Equities analysts predict that Ardent Health Partners, LLC will post 1.23 EPS for the current year.

Institutional Trading of Ardent Health Partners

Large investors have recently modified their holdings of the business. Point72 Asia Singapore Pte. Ltd. purchased a new stake in Ardent Health Partners in the 4th quarter valued at approximately $27,000. US Bancorp DE acquired a new position in shares of Ardent Health Partners in the fourth quarter worth $31,000. R Squared Ltd acquired a new position in shares of Ardent Health Partners in the fourth quarter worth $37,000. BNP Paribas Financial Markets purchased a new stake in shares of Ardent Health Partners in the third quarter valued at $42,000. Finally, New York State Common Retirement Fund acquired a new stake in shares of Ardent Health Partners during the fourth quarter valued at $48,000.

About Ardent Health Partners

(Get Free Report)

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.

Featured Articles

Receive News & Ratings for Ardent Health Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ardent Health Partners and related companies with MarketBeat.com's FREE daily email newsletter.